A strong patent needs good insurance

The European Patent Office (EPO) has published its statistics for 2017. Belgian patent applications stand out for their soundness. Belgium submitted 2,155 applications, or 1.9 per cent more than in 2016, itself already a record year. A strong patent also needs good insurance: Vanbreda has developed a policy that helps you protect your rights in the event of a breach or a dispute.

A strong patent needs good insurance

Solid Belgian applications

The number of Belgian patents awarded was 9.1 per cent higher last year. There is obviously a time lag between the number of patent applications and the number approved, but the increase in the number of Belgian patents approved since 2013 is much higher (+65%) than the increase in the number of applications (+14.5%). This is an indication of the good quality of the Belgian patent submissions.

Around 19 per cent of the Belgian submissions came from the medical, biotech and pharmaceutical sector. This is an increase of 2 percentage points. 64 per cent of all applications come from Flanders. This puts Flanders in third place among the European regions, the same as Belgium’s ranking among countries.

The leader in the number of patent applications to the EPO last year was Solvay (355), ahead of Imec (191), Umicore (79), Melexis (53) and the Flemish Institute of Biotechnology (45). The University of Ghent submitted 40 applications, five more than the Catholic University of Leuven.

Protect your intellectual property

You can stay ahead of your competitors not only by registering your intellectual property, but also by protecting your patent. The Intellect Protect insurance developed by Vanbreda Risk & Benefits is a policy that helps you to protect your rights in the event of a breach or a dispute.

This policy protects your company if it is held liable for breaching another party’s intellectual property rights. It also covers the costs you incur when taking legal action against any firm that has violated your property rights.

Subscribe to our newsletter.